Trial NCT03430791

View at ClinicalTrials.gov 
Org. Study IDs: 2017-ODI-002

Last trial update was posted on 2023-02-02

MeSH Interventions

Ipilimumab Nivolumab

MeSH Conditions

Glioblastoma Recurrence

Other Conditions

Recurrent Glioblastoma

Stopping Reasons

Study Investigator/Sponsor decided to end enrollment earlier.

Limitations And Caveats

Did not accrue the target number of participants needed to achieve target power and statistically reliable results.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID